The global mice model market size is expected to reach USD 2.49 Billion by 2028 registering a CAGR of 6.6% over the forecast period, according to the latest report by Reports and Data.
Market revenue growth is driven by a key factor such as constantly increasing biomedical research in various developed as well as developing countries in the last few decades. Animal models, especially mice models, typically receive a significant share of research funding. This is a primary driver expected to support the growth of the global mice model market.
The use of mice models has increased in the last few years, as a result of developments in gene-editing technology, which has greatly aided scientists in the research and development of new drugs. These models are used in a wide range of clinical trials, including oncology and immunology. In response to the increasing demand for personalized drugs, the scope for genetically modified humanized mice models has expanded.
The use of mice models in cancer research is driving demand for mice models. This is critical because mice models are used to investigate the unintentional association between candidate cancer genes and carcinogenesis, as well as to create and evaluate new therapies. In 2017, the American Cancer Society estimated that 1,688,780 new cancer cases were diagnosed in the United States. Cancer claimed the lives of nearly 600,920 Americans in 2017, or about 1,650 people every day. In the United States, cancer is the second leading cause of death, after heart disease, accounting for almost one out of every four deaths. Furthermore, the growing geriatric population in the United States is a factor contributing to the country's rising cancer rates. In the United States, for example, people aged 50 and over are diagnosed with 87 percent of all cancers. Furthermore, the world's increasing geriatric population is a major contributor to rising cancer prevalence.
Animal protection and health laws and regulations have resulted in more restrictive practices and bans on the use of animals for different purposes. In the last decade, various countries have banned the use of animals in the cosmetics industry. Complying with required regulations for use of animal models can be time-consuming and inconvenient, which could hamper the market growth to some extent.
Market Overview:
The pharma and healthcare industry is at a crossroads. Patients are benefiting from the promise of cell and gene therapies; uncommon diseases that were previously thought to be incurable are on the verge of finding true treatments. Artificial intelligence (AI) and machine-learning technologies are creating hopes that therapy discovery and development would be more innovative, as well as faster and cheaper. Manufacturing, the supply chain, and the entire healthcare ecosystem all have the potential to benefit from data-driven initiatives. Consumer attitudes and behaviors are shifting in a variety of ways, from the growing use of technology and willingness to share data to an interest in using tools to make prescription and treatment decisions. Such factors will drive pharma and healthcare market growth in the coming years.
Key Players covered in this report are:
Charles River, Envigo, Taconic Biosciences, Inc., genOway, Janvier Labs, and Hera BioLabs.
Mice Type Outlook (Revenue, USD Billion, 2018–2028)
- Inbred
- Outbred
- Knockout
- Hybrid
- Others
Technology Outlook (Revenue, USD Billion, 2018–2028)
- CRISPR
- Microinjection
- Embryonic Stem Cell Injection
- Nuclear Transfer
- Others
Use Outlook (Revenue, USD Billion, 2018–2028)
- Human
- Veterinary
Application Outlook (Revenue, USD Billion, 2018–2028)
- Research Development
- Infectious Disease
- Immunological Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Genetic Diseases
- Neurological Diseases
- Others
- Production and Quality Control
- Academics
- Others
End Use Outlook (Revenue, USD Billion, 2018–2028)
- Pharmaceutical
- Biotechnology
- Cosmetics
- Others
- Organizations
- Government
- Non-government
- Academic and Research Institutes
- Contract Research Organizations (CRO)
Based on Region market is segmented into:
- North America
- Europe
- Asia-Pacific
- South America
- Middle East Africa
Request a sample Report of Mice Model Market @ https://www.reportsanddata.com/request-customization-form/3994
Major Points covered in this report are as below:
• The Mice Model industry development trends and marketing channels are analyzed. The feasibility of new investment projects is assessed and overall research conclusions are offered.
• With the tables and figures, the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
• Development policies and plans, manufacturing processes, and cost structures are also analyzed. This report also states import/export consumption, supply and demand figures, cost, price, revenue, and gross margins.
• The Mice Model Market report provides key statistics on the market status of the Mice Model manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.
We can also provide customized data for separate regions like North America, United States, Canada, Mexico, Asia-Pacific, China, India, Japan, South Korea, Australia, Indonesia, Singapore, Rest of Asia-Pacific, Europe, Germany, France, UK, Italy, Spain, Russia, Rest of Europe, Central South America, Brazil, Argentina, Rest of South America, Middle East Africa, Saudi Arabia, Turkey, Rest of Middle East Africa
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
